Eight Sleep, a startup based in New York that specializes in "sleep fitness" technology products, revealed that it has successfully raised $100 million in its latest funding round as of Tuesday.
With initial public offerings (IPOs) and mergers & acquisitions (M&A) exits limited this year, many companies have turned to secondary share sales. Gus Resendiz, a partner at Foley & Lardner, shares insights in this Crunchbase News Q&A on why the secondary market is expanding yet still struggles to meet investor demand.
The United States healthcare system, with its vast $4.5 trillion annual expenditure, remains one of the largest and most intricate worldwide. Despite this, it continues to underperform, presenting significant opportunities for transformative disruption. Guest author Jason Robart highlights how private capital infusion and cutting-edge innovation are essential to revitalizing and improving this critical sector.
The San Francisco Bay Area and a few other coastal metropolitan regions continue to attract the majority of venture capital investment. Despite this concentration of funding in select areas, other states remain actively involved in the startup ecosystem and have not withdrawn from the competitive landscape.
With billions in venture capital shifting focus from traditional SaaS to AI platforms and startups, SaaS founders, investors, and customers are driving the sector towards a fresh wave of innovation. In this guest commentary, Ivan Nikkhoo of Navigate Ventures analyzes how startups can remain relevant and competitive in a rapidly evolving SaaS landscape.
Guest author Aron Solomon presents a cautionary perspective on technology's role, asserting this isn't merely about faster or more efficient solutions. Instead, he highlights a critical shift: technology advancing not because it surpasses human capabilities, but because the human presence in certain areas has diminished significantly.
In 2025, the biotech, drug discovery, and medical device sectors have experienced notably low IPO activity, with only 16 funded U.S. startups debuting on Nasdaq or the New York Stock Exchange, according to Crunchbase data. This marks one of the slowest years for biotech IPOs in recent times.
This week saw a cooling off in giant funding rounds, yet several significant investments emerged in sectors such as therapeutics, enterprise software, rare earth magnets, and artificial intelligence (AI). While the largest megadeals paused, innovation and funding activity in key areas continued to advance.
While strategies like growth hacking and marketing automation are important, in the fintech sector, the power of a warm introduction and personal connections remains unmatched. Guest author Itay Sagie explains why these human elements, combined with compliance, can create the strongest alliances for securing funding.
Beyond the prominent generative AI firms like OpenAI, Anthropic, and xAI, unicorn companies building AI solutions tailored for specific sectors such as legal technology, marketing, and healthcare are securing follow-on funding rapidly. Additionally, industries like defense technology, cybersecurity, and fintech also feature unicorns accelerating their fundraising efforts.